jimmy667 post#204374
Great post and I completely agree !
TGD knows what he's got ( as he is behind the curtain ) and I believe he is intent on turning AVXL into an extremely large company. As you say, he is " running silent and deep " right now and is purposely avoiding the distractions ( frivolous lawsuits, hostile takeover attempts, etc. ) that could result from putting out Biogen-like pump pieces. He knows the only thing that has credibility with the scientific and medical communities, and with Wall Street, are trial results. And, I agree with you that TGD is setting up a 1-2 punch ( Rett the PDD missiles " fired from a submerged position " ) that will both vaporize the shorts and simultaneously provide great protection from unwanted takeover attempts as institutional buying floods in and the share price skyrockets.
With 2-73 having been in the Australian AD trial for 4+ years, it seems TGD feels 2-73 has a very good of early, conditional approval following successful phase 2 trials for Rett and PDD in Australia, and given the $1 million stockpile of product and the shelf registration, it appears he is preparing to go it alone for those two indications. AD approval should follow about a year later but in light of the huge unmet need and having all the data from the extended AD trial, I wouldn't rule out early, conditional approval for AD.
So, although it's hard at times to be patient, given the current size of the company and its realistic capabilities at this time, and the obvious cabal manipulation, I think TGD is playing this exactly right - run silent and focus on completing the trials.
It's almost mind boggling to think what Anavex could be worth in five years.
In Missling I Trust !!
jmvho
Market Data 
Markets 
